195rar Review

To prove that SYK was directly talking to FLT3, scientists needed to break the physical connection between them. They focused on a specific part of the SYK protein called the .

In a study published in , scientists investigated a protein called SYK (Spleen Tyrosine Kinase). They knew SYK was present in blood cancers but weren't sure exactly how it contributed to the disease. They discovered that SYK acts as a "partner in crime" with another protein called FLT3 , which is frequently mutated in leukemia patients. The 195RAR Mutation

The story of is a technical one, centered on the SYK protein and its role in Acute Myeloid Leukemia (AML) . Researchers used this mutation to unlock a secret about how cancer cells survive and resist treatment. The Mystery of the SYK Protein 195rar

When the researchers used the SYK mutant with the change, the protein could no longer bind to FLT3. This was a "Eureka" moment because it proved:

SYK must physically touch FLT3 to activate it. To prove that SYK was directly talking to

By changing a specific sequence of amino acids from to GAL , researchers created a mutant version of the protein.

In scientific research, "195RAR" refers to a specific genetic mutation used to study how certain proteins interact within the body, particularly in the context of cancer development. They knew SYK was present in blood cancers

Highly active SYK can help cancer cells ignore standard treatments meant to kill FLT3-driven leukemia.